Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH.
Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.
This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.
LATEST FROM THE BLOG
for Psychiatric Medications:
All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry.
MGH Perinatal Depression Scale Mobile App
Are you pregnant? Do you own a smart phone? Get the MGH Perinatal Depression Scale app.
Are you experiencing symptoms of menopause and feeling depressed or down? You may be eligible for a research study at Massachusetts General Hospital evaluating how a medication treats menopausal depression and other symptoms of menopause.
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, stimulants, and atypical antipsychotics that many women take during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders.
TO PARTICIPATE CALL TOLL-FREE:
If you are a mother who has experienced an episode of postpartum psychosis within the past ten years, you could help us to better understand this disorder. Researchers at Massachusetts General Hospital’s (MGH) Ammon-Pinizzotto Center for Women’s Mental Health are announcing the launch of a new research study called the MGH Postpartum Psychosis Project (MGHP3).
People who have been depressed in the past are at risk of becoming depressed in the future, and depression during pregnancy is all too common. Our study seeks to determine whether a digital mindfulness-based cognitive therapy (MBCT) platform is effective in preventing depressive relapse during pregnancy and the post-partum period.